ArticleCancer research2019

PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness.

Jianfeng Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.